On Monday, Phio Pharmaceuticals Corp (NASDAQ: PHIO) opened lower -5.74% from the last session, before settling in for the closing price of $2.96. Price fluctuations for PHIO have ranged from $0.97 to $9.79 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 82.60% at the time writing. With a float of $4.74 million, this company’s outstanding shares have now reached $4.78 million.
In an organization with 5 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Phio Pharmaceuticals Corp (PHIO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Phio Pharmaceuticals Corp is 1.26%, while institutional ownership is 3.99%. The most recent insider transaction that took place on May 21 ’25, was worth 5,310. In this transaction Chairman, Pres & CEO of this company bought 3,000 shares at a rate of $1.77, taking the stock ownership to the 22,449 shares. Before that another transaction happened on May 22 ’25, when Company’s Chairman, Pres & CEO bought 1,200 for $1.78, making the entire transaction worth $2,136. This insider now owns 23,649 shares in total.
Phio Pharmaceuticals Corp (PHIO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 82.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 64.39% during the next five years compared to 66.30% growth over the previous five years of trading.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Trading Performance Indicators
Check out the current performance indicators for Phio Pharmaceuticals Corp (PHIO). In the past quarter, the stock posted a quick ratio of 10.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.51, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -0.83 in one year’s time.
Technical Analysis of Phio Pharmaceuticals Corp (PHIO)
Let’s dig in a bit further. During the last 5-days, its volume was 2.06 million. That was inferior than the volume of 5.39 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 75.61%. Additionally, its Average True Range was 0.26.
During the past 100 days, Phio Pharmaceuticals Corp’s (PHIO) raw stochastic average was set at 51.12%, which indicates a significant decrease from 70.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 118.99% in the past 14 days, which was lower than the 138.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.91, while its 200-day Moving Average is $2.33. However, in the short run, Phio Pharmaceuticals Corp’s stock first resistance to watch stands at $3.14. Second resistance stands at $3.49. The third major resistance level sits at $3.73. If the price goes on to break the first support level at $2.55, it is likely to go to the next support level at $2.31. The third support level lies at $1.96 if the price breaches the second support level.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Key Stats
There are currently 4,798K shares outstanding in the company with a market cap of 13.39 million. Presently, the company’s annual sales total 0 K according to its annual income of -7,150 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -1,770 K.
